March 2024
US FDA approves first drug for fatty liver disease NASH
Health 14 March 2024, 2:54 pm 1 minute Reuters was first to report on the FDA approving Madrigal Pharmaceuticals’ drug Rezdiffra, an oral drug to treat a fatty liver disease known as non-alcoholic steatohepatitis (NASH). The approval was the first of its kind. Market Impact The company’s shares surged 24% in extended trading. Article Tags […]
Novo Nordisk says experimental drug amycretin show 13% weight loss in trial
Business & FinanceHealth 07 March 2024, 2:04 pm 1 minute Reuters was first to report on the early trial data for Novo Nordisk’s highly anticipated experimental drug amycretin which showed that participants had a weight loss of 13.1% after 12 weeks, prompting the company’s shares to rise to record highs and placing it above Tesla […]
Major Bayer shareholder Harris backs CEO’s focus on internal restructuring
Business & FinanceHealth 07 March 2024, 1:56 pm 1 minute Reuters exclusively reported that major Bayer shareholder Harris Associates came out in strong support of the drugmaker’s decision to suspend work on breaking up the diversified group, giving some breathing room to its embattled CEO. Market Impact The news caused Bayer’s shares to significantly narrow […]
UN-backed bank group seeks to avoid departures with new climate guidelines
Business & FinanceEnvironment 05 March 2024, 2:23 pm 1 minute Reuters exclusively reported that a United Nations-backed alliance of banks is proposing its members disclose more information on their commitments to tackle climate change without requiring them to coordinate action, in a compromise it hopes will prevent departures. Market Impact The Net-Zero Banking Alliance (NZBA), […]
Insights From 14th Global Investment Immigration Summit
The 14th Global Investment Immigration Summit at the Shangri-la Hotel in Delhi The 14th Global Investment Immigration Summit at the Shangri-la Hotel in New Delhi on February 10, 2024 marked a significant milestone in India’s quest for international opportunities. The event witnessed a remarkable surge in attendees, indicative of the growing interest among Indian investors […]
Alopecia and me: ‘I embrace it, but I’d love my old hair back’
People living with one of the most common types of alopecia could soon have access to treatment on the NHS in Scotland for the first time. The drug – called Ritlecitinib – will go before the Scottish Medicines Consortium this week after it was approved for NHS use in England last month. Although the daily […]